2.20
price up icon1.38%   0.03
after-market Handel nachbörslich: 2.19 -0.01 -0.45%
loading
Schlusskurs vom Vortag:
$2.17
Offen:
$2.16
24-Stunden-Volumen:
93,309
Relative Volume:
0.06
Marktkapitalisierung:
$5.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.28M
KGV:
-0.7309
EPS:
-3.01
Netto-Cashflow:
$-9.78M
1W Leistung:
+4.27%
1M Leistung:
+8.91%
6M Leistung:
-73.43%
1J Leistung:
-63.75%
1-Tages-Spanne:
Value
$2.10
$2.25
1-Wochen-Bereich:
Value
$2.05
$2.25
52-Wochen-Spanne:
Value
$1.62
$14.67

Ensysce Biosciences Inc Stock (ENSC) Company Profile

Name
Firmenname
Ensysce Biosciences Inc
Name
Telefon
(858) 263-4196
Name
Adresse
7946 IVANHOE AVENUE, LA JOLLA
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ENSC's Discussions on Twitter

Vergleichen Sie ENSC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENSC
Ensysce Biosciences Inc
2.20 5.00M 0 -11.28M -9.78M -3.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten

pulisher
Jul 22, 2025

When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Ensysce Biosciences Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Ensysce Biosciences Inc. a good long term investmentConsistent wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Ensysce Biosciences Inc. stockFree Capital Efficiency Planning - printweek.in

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Ensysce Biosciences Inc. stock priceRobust financial gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Ensysce Biosciences Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Ensysce Biosciences Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Ensysce Biosciences Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Where are the Opportunities in (ENSC) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World

Jul 08, 2025
pulisher
Jun 24, 2025

FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan

Jun 24, 2025
pulisher
Jun 21, 2025

(ENSC) Investment Analysis - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 15, 2025

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor - Investing.com

Jun 05, 2025
pulisher
Jun 04, 2025

Ensysce Flat on Receiving Grant - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan

Jun 04, 2025
pulisher
Jun 01, 2025

Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 17, 2025

Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World

May 17, 2025
pulisher
May 16, 2025

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks

May 15, 2025
pulisher
May 14, 2025

Ensysce Biosciences: Is Now the Time to Bet on a Turnaround? - AInvest

May 14, 2025
pulisher
May 13, 2025

Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan

May 13, 2025
pulisher
May 12, 2025

Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan

May 12, 2025
pulisher
May 11, 2025

Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World

May 11, 2025

Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):